Skip to content

Free cash flow at other companies

Halliburton logo
HalliburtonHAL
$81M+8.0%
Schlumberger
 logo
Schlumberger SLB
$144M-45.0%
Baker Hughes logo
Baker HughesBKR
$164M-59.9%
Forum Energy Technologies logo
Forum Energy TechnologiesFET
$1.37M-81.0%
RPC logo
RPCRES
-$932K-112%
Flowco Holdings Inc. logo
Flowco Holdings Inc.FLOC
$52.32M+256%

Other financials

Income statement

See full
Revenue$121.8M-1.4%
Operating income$1.9M-57.3%
Net income-$789.0K-412%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$22.8M+3.2%
Total debt$167.8M-6.8%
Total equity$268.9M+6.1%
Total assets$587.7M+0.3%

Cash flow

See full
Operating cash flow$4.0M-40.5%
CapEx$3.4M+23.8%

Valuation

See full
Market cap$503.38M-13.5%
Enterprise value$648.4M-12.3%
P/E17.3×-3.4×
P/S-0.2×

Profitability

See full
Operating margin10.3%-0.2pp
Net margin5.5%+0.1pp
FCF margin4.3%-4.6pp

Returns & leverage

See full
Return on equity11.1%-0.4pp
Debt / equity0.6×-0.1×
Current ratio-0.2×

Where this comes from

Calculated from Core Laboratories’s reported figures.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Laboratories's free cash flow?
Core Laboratories (CLB) reported free cash flow of $517K in Q1 2026.
How has Core Laboratories's free cash flow changed year-over-year?
Core Laboratories's free cash flow decreased by 86.7% year-over-year, from $3.88M to $517K.
What is the long-term trend for Core Laboratories's free cash flow?
Over 3 years (2021 to 2025), Core Laboratories's free cash flow has grown at a 3.9% compound annual growth rate (CAGR), from $23.04M to $25.82M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.